Jun 17 2011
CoreLab Partners, Inc, the global entity resulting from the merger between RadPharm, Inc and Medifacts International, will showcase several new technological solutions to coincide with the upcoming DIA meeting in Chicago, Illinois to be held from June 20 - 23, 2011.
"I am pleased to announce that as a part of an on-going commitment to our sponsor partners to deliver the highest possible quality through a cost effective, technologically driven process, we are positioned to launch another series of innovative and enabling solutions in both our ImagEngineSM and WebHeart® platforms", said CoreLab Partners' President and CEO, Dr. Mike Woehler. "Our proprietary advanced imaging application, ImagEngineSM, will perform 3D and volumetric measurements while incorporating multi-planer reconstruction tools with lesion propagation which will expand our therapeutic reach and addresses the growing needs for this type of image analysis going forward. Further, we will add a highly-automated algorithmic solution to conduct Thorough QT (TQT) studies that is fully integrated with our WebHeartSM system and complements our current suite of ECG, Holter, ABPM, and HRV/HRT services", added Woehler.